271 - What’s New in Respiratory Viruses

Saturday, October 22, 2022

3:15 PM – 4:30 PM US ET

Location: 143 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Christine Johnston, MD, MPH

Associate Professor
Medicine
University of Washington
Seattle, Washington, United States

Disclosure(s): Abbvie: Advisor/Consultant (Terminated); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Faculty(s)

Helen Chu, MD, MPH

Associate Professor
Medicine
University of Washington
Seattle, Washington, United States

Disclosure(s): Cepheid: Reagents (); Ellume: Advisor/Consultant (); Gates Ventures: Grant/Research Support (); Merck: Advisor/Consultant (); Pfizer: Advisor/Consultant ()

Slides
Nelson Lee, MD, FRCP(Lond), FIDSA

Professor, Institute for Pandemics
University of Toronto
Toronto, ON, Canada

Disclosure(s): bioStrategies: Honoraria (Terminated); Clarion Healthcare: Honoraria (Terminated); Genetech: Honoraria (Terminated); Gilead Science: Advisor/Consultant (Terminated), Honoraria (Terminated), travel to meetings (Terminated); Hoffmann-La Roche: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Janssen Pharmaceutical Company of J&J: Advisor/Consultant (Terminated), Honoraria (Terminated); Sanofi Pasteur Inc.: Advisor/Consultant (Terminated), Honoraria (Terminated); Shionogi, Inc.: Advisor/Consultant (Terminated), Honoraria (Terminated), travel to meetings (Terminated); Technospert: Honoraria (Terminated)

Slides
Alicia Fry, MD, MPH

Medical Epidemiologist
Centers for Disease Control and Prevention
Atlanta, GA, United States

Disclosure(s): No financial relationships to disclose

Slides

Moderator(s)

Meagan Deming, MD, PHD

Assistant Professor
Center for Vaccine Development, University of Maryland Medical Center
Baltimore, MD, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Christine Johnston, MD, MPH: Abbvie: Advisor/Consultant (Terminated); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Helen Y. Chu, MD, MPH: Cepheid: Reagents (); Ellume: Advisor/Consultant (); Gates Ventures: Grant/Research Support (); Merck: Advisor/Consultant (); Pfizer: Advisor/Consultant ()

Nelson Lee, MD, FRCP(Lond), FIDSA: bioStrategies: Honoraria (Terminated); Clarion Healthcare: Honoraria (Terminated); Genetech: Honoraria (Terminated); Gilead Science: Advisor/Consultant (Terminated), Honoraria (Terminated), travel to meetings (Terminated); Hoffmann-La Roche: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Janssen Pharmaceutical Company of J&J: Advisor/Consultant (Terminated), Honoraria (Terminated); Sanofi Pasteur Inc.: Advisor/Consultant (Terminated), Honoraria (Terminated); Shionogi, Inc.: Advisor/Consultant (Terminated), Honoraria (Terminated), travel to meetings (Terminated); Technospert: Honoraria (Terminated)

Alicia M. Fry, MD, MPH: No financial relationships to disclose

Meagan Deming, MD, PHD: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss developments in novel vaccines and therapeutics to prevent and treat RSV;
identify epidemiologic changes in influenza and non-influenza respiratory viruses during the COVID-19 pandemic;
describe anticipated trends in respiratory virus epidemiology in upcoming respiratory virus seasons

Presentations:

3:15 PM – 3:40 PM US ET

Updates in RSV Epidemiology, Therapeutics and Prevention
Speaker: Helen Y. Chu, MD, MPH – University of Washington
3:40 PM – 4:05 PM US ET

Non-Influenza Respiratory Virus Infections: Impact, Challenges and Countermeasures
Speaker: Nelson Lee, MD, FRCP(Lond), FIDSA – University of Toronto
4:05 PM – 4:30 PM US ET

Influenza During the COVID-19 Pandemic: What Happened and What's Next?
Speaker: Alicia M. Fry, MD, MPH – Centers for Disease Control and Prevention